Studies on non-steriodal estrogens: The synthesis of 1-(4-hydroxybenzoyl)-2-phenyltetralin by Wengert, Stephanie Marina
P H V r a w T i  O r  I L U N Q H
m t 1C . . 8 8
THIS IS TO CERTIFY THAT THE THESIS PREPARED UNDER MY SUPERVISION »Y
ENTITLED. STUDIES ON NON-STEROIDAL ESTROGENS i THE SYNTHESIS
OF 1 - (4-HYDROKYBENZOYL)-2-PHENYLTETRALIN.
IS APPROVED BY ME AS FULFILLING THIS PART OF THE REQUIREMENTS FOR THE
DEGREE OF............... RMHKinR.QE..SCU3CB. jELCHBCSEBE
Amovss
• M H I t l l l M t n H H m H I I M I I H m w t M f f M
iM t m t o r  in  Q w i f i
y^rH EAD  OF DEPARTMENT O F ...{ ^ + ~ * k h t J
011*4
STUDIES ON NON-STEROIDAL ESTROGENS: THE SYNTHESIS OF K i ­
r n
STEPHANIE MAMNA WENGERT
THESIS 
FOR THE
KM REE OF BACHELOR OF SCIENCE 
IN
CHEMISTRY
COLLEGE OF LIBERAL ARTS AND SCIENCES 
UNIVERSITY CM1 ILLINOIS 
URBANA, ILLINOIS
1 9 8 8
ABSTRACT
l-(4*Hydroxybensoyl)*2-phenyltetralin 2  ha> been synthesised in an ongoing 
project to optimize the relative binding affinity o f tetraiin derivatives fbr the 
estrogen receptor. This compound has been modeled after Trioxifene 
Mesylate, a potent antiestrogen. While the RBA of this tetraiin 2  is rather 
low (0.068%, estradiol I f '% ), it may be possible to improve receptor binding 
by varying the hydroxyl substitution pattern within the molecular 
framework. The synthesis o f several l-aroyl-2-phenyltetralin derivatives, 
as well as several 3,4-dihydronaphthalene derivatives, is underway.
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INTRODUCTION
Through the years, breast cancer has remained one o f the leading 
causes o f death among women. Much effort has been put forth to delineate 
dearly the etiology o f the disease with the intent o f developing improved 
diagnostic and treatment methods. It has been known for some time that a 
majority o f breast tumors are rich in a particular protein, the estrogen 
receptor.1’2 Women with such tumors have been found to respond favorably 
to endocrine therapy and, therefore, the estrogen receptor and the actions o f 
the estrogen receptor warrant attention.
The estrogens are a class o f cholesterol-derived sex hormones. 
Specifically, the estrogens are responsible for primary and secondary 
sexual female development, and the upkeep o f both the reproductive tract 
and mammary tissue o f the female. Each estrogen can be considered a 
derivative o f an eighteen carbon nucleus (Figure 1). Naturally occurring 
estrogens include estradiol 1, estriol 2, and estrone ^.(Figure 2).
Figure 1-
The generally accepted mechanism o f action for steroidal hormones, as 
proposed by Gorski,3 suggests that the steroid molecule is able to diflhse 
freely through both the plasma and nuclear membranes. Once in the 
nucleus, the hormone then binds to a hormone specific receptor (Figure 3). 
As a complex, this unit is able to interact with specific chromosomal
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threw#* a mediator protein which proceeds io act on the chromatin* This 
binding to the chromatin causes a stimulation of certain DHA sequences 
and. in turn, an increase in the synthesis of mRKA for this particular 
sequence. The end result of steroidal stimulation is the increased synthesis 
of target tissue protein products. The estrogens act by this mechanism, and 
it has been observed that many human breast cancers may bo dependent 
upon the estrogen receptor and its actions and, therefore, possibly this 
mechanism, for continued proliferation,5
Antiestrogens have been proven invaluable in the treatment o f 
endocrine dependent tumors. How well a breast cancer patient responds to 
endocrine thorapy has been found to be related to the content o f estrogen 
receptor in the tumor. McGuire, » i  al have presented rough guidelines 
correlating the richness o f estrogen receptor in the tumor to Hie success o f 
endocrine therapy. They have found these patients with tumors which had 
at least 100 fcmtomoles EH/ mg cytoeolic protein, or strongly ER+ tumor, 
h id  • response rate o f 80.7%; those with less than 100 fmol/mg had less 
than a 48% response rate to endocrine therapy. It is obvious that endocrine 
treatment can prove beneficial to those women with an ER+ tumor. 
Therefero, the search for a potent antiestrogen has been an energetic one.6
Anticsteogena are able to prevent the endogenous effects o f natural 
estrogens through competitive inhibition for the estrogen receptor. Upon 
binding o f the antieateegen-receptor complex to the target DNA, the 
complex date not initiate or evoke the normal events a natural osteogen 
would, thereby causing a roproeaion o f the synthesis o f protein products 
and, hopefully, the growth o f the tumor. Several anticateogene have proven 
te be petent and therefore valuable antiestrogena. Tamoxifen and
3
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FIGURE 3
Nafoxidine, both shown in Pig, 4 , has been shown to inhibit the growth of 
ER+ tumors in the MCF-7 human breast cancer cell line.7 In general, those 
tumors with a prominent (60-70) percentage o f ER seem to respond very well 
to endocrine therapy.
H ie human estrogen receptor eDUA has recently been sequenced by 
Chambon and Greene.8 They have identified six domains (A-F) and believe 
that hormone binding occurs in domain E, a hydrophobic portion o f the 
protein containing ca. 220 amino adds. The specific nature o f the binding 
pocket, more specifically the amino acid residue(s) responsible for hormone 
binding, is still uncertain.
Kevin Pinney, a senior chemist working for Dr. John 
Katzenellenbogen, has used a technique known as ohotoaffinity labeling to 
aid in the localization and identification o f the active site o f the estrogen 
receptor. A photoaffinity reagant (PAR) is a molecule which itself is inert, 
bud upon photolysis, becomes an extremely reactive intermediate. This 
intermediate can then proceed to attack the target receptor. Typically, the 
photoaflMpy raapsat is incubated with the target receptor and, once bound 
to the reactive intermediate can be generated at will.. An
effective photoaffinity reagant then attacks the target site and forms a 
covalent bond with a functionality in the target site Once labeled, 
identification o f the region to which the PAR is bound can be established by 
protein degradation o f the complex, followed by isolation of the PAR-binding 
site region.9
Pinney has incorporated the acyl azide moiety into two potential PARs; 
azido tetralin JJh and a benzothiophene derivative XL These molecules, 
along with their relative binding affinities, are shown in Table 1. While the
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Hbinding affinities o f the** PARa are respectable, they are subject to 
improvement.
Mittal and Durani have studied strueture-estivity relationship in the Z- 
triarylprepenone system (Z-TAP) 'Figure 5).)0 Their findings for this 
system suggest that receptor binding is optimised when X, Y ■ OH, and Z ■ 
H. In light o f this discovery, we have initiated an analogous study applied 
to the tetralin (Figure 6) and corresponding 3,4-dihydronaphthalene 
(Figure 7) derivatives. The compounds in Figures 6 and 7 are those 
proposed for synthesis. There are several reasons why this study is 
valuable. First o f all, a hydroxylation pattern that maximizes the relative 
binding affinity of the tetralin and the 3,4-dihydronaphthalene system can 
be found either class can be found. Secondly, the study will give 
information concerning the importance o f the conformation of the C -l, C-2 
bond for estrogen receptor binding. The second class o f molecules (the 8,4- 
dihydronaphthalenes) has a greater degree o f rigidity than the tetraMn 
class due to the double bond at C -l. The collective set o f RBAs from each 
daos should be indicative o f which molecular skeleton exhibits the best 
overall binding properties.
Figure 5 Z-TAPs 9
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We haw synthesised l-(4-hydroxybenioyl)-2-phenyhetralin in teven steps 
uriag a eemi-convergent route. This molecule was modeled on early work 
dime by Pinney and Katzenrilenbogen. Hie major points of synthetic 
connection are shown in Fifure 8.
Figure 8 .
The tosylhydrasone 1ft was prepared according to Paquette.11
posribly due to arid residue on the glassware.
The toeyfeydraaone 1ft urns depreSenated by exposure to n-BuLt in cold 
N,N,N' N’-tetramethylethylenediamine (TMEDA). The depretenated 
tosylhydrasone Id rearranged to a vinyl lithium intermediate 1ft upen 
warmiag to roam temperature, (hue recoded, the vinyl carbanien, an 
intermediate stable at room temperature for several hours, was quenched
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The only real problems encountered with this carbanion formation 
were the absolute necessity of dryness of both glassware and chemicals, 
and maintaining the temperature at -45°C during carbanion formation. To 
ensure the success o f the vinylation, the tosylhydrazone was dried in a 
drying pistol at a temperature of ca. 50°C for at least 24 hours before the 
reaction was to take place. In all cases, the reaction produced the vinyl tin 
species m  as a mixture with several other substances, most o f which could 
be removed upon purification.
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Vinyl stannane Ifi was first purified by Kugelrohs distillation. This 
procedure removed a majority o f the excess tributyltin chloride. The pot 
residue from the distillation was then purified further by flash column 
chromatography with the intent o f separating the vinyl stannane lf i  from 
the major by-product, the olefin 12. Complete separation was never 
achieved, but the synthesis could be carried on using a mixture o f Ifi and 
12. To determine the ratio o f 16/17. the mixture was analyzed by gas
chromatography. The average ratio o f vinyl stannane to olefin was ca. 3 to
1.
Palladium(II) coupling o f 4-methoxybenzoyl chloride lf i  with 
vinylstannane lf i  was performed according to Milstein and Stille.12 
Benzylchlorobis(triphenylpho8phine)palladium(H) was the catalyst used in 
this coupling reaction. In its active form, as a bis(triphenylphosphine)
Pd(0) species, the catalyst goes through steps of oxidative addition, 
metathesis, and reductive elimination to catalyze the coupling o f the vinyl 
stannane lfi  and acid chloride lfi, yielding the aroylated product lfi. Yields 
from this reaction have been consistently poor: 6 to IS percent. Different 
solvents •- HMPA, ethyl ether, and THF -- have all been tried, none of which 
resulted in any greater yield. A major by-product o f this reaction was 
anisoic anhydride 20.
Aroylation of the vinylstannane lfi was initially attempted through a 
modification o f the Shapiro reaction.13 The vinyl carbanion lfi  was 
generated and allowed to react with the acid chloride lf i  through an inverse 
addition. In all cases, the only identified product was anisoic anhydride 20.
f ~ \  H «
ch3o— • €  7-—c— o— c—^  0CH3
1 0
15
In all aroylations, 4-methoxybenzoyl chloride lf i  was either purchased from 
Aldrich, or was prepared by treatment of 4-methoxybenzoic acid with 1.7
16
equivalents o f thionyl chloride at reflux. This synthesis gave the resulting 
add chloride in excellent yield (87-90%).
o
N
C— Cl
SOCI2, 1.7 eq 
Reflux, 87%
OCH,
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STEP 2; Phenvlation o f C-2
Phenylation at the C-2 position was achieved by corrugate addition of 
lithium diphenylcuprate. This conjugate addition resulted in a mixture of 
diastereomers; fiig and trans-isomers were present in a ratio o f 3 to 1, as 
approximated by NMR. Yields for this product mixture were consistently 
20-25%.
Methyl ether deprotection of the diastereomers 21 was achieved with 
excess o f BFaCSMea) complex., yielding a diastereomeric mixture o f l-(4-
hydroxybenxoyl)-2-phenyltetralin 2 ,  the target compound. The 
diastereomeric crystals could not be separated and, therefore, the mixture 
was submitted for a Relative Rinding Assay, or RBA.
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RECEPTOR BINDING AFFINITIES
As a test o f this molecule's affinity for the estrogen receptor, a 
competitive binding assay was set up between the target compound and 
estradiol, the normal ligand for the estrogen receptor. The receptor source 
that has been used in our lab is either lamb or immature rat uteri. As this 
is a relative binding assay, all RBAs are reported with respect to estradiol, 
which has been assigned an RBA of 100. A comparison o f RBAs for various 
instructive molecules can be found in Table II.
The RBA o f our target compound was quite low (0.058%). While it would 
have been encouraging to see a higher binding affinity, this result is not 
surprising. The very low binding affinity (0.008%) o f 24 suggests that a C-2 
phenyl is necessary for binding. It has also been suggested that a pairing of 
functional groups •• hydroxyl, ester, azide •• on the C-3 position o f the "A" 
ring and on C-4 o f the C -l benzoyl group are important for high binding 
affinity.
too small to 
m oasurt
0.017 9 
0.22 13 
0.012 13
0.088
100
7.70 
0.008 9
EXPERIMENTAL METHODS 
GENERAL
All melting points have been determined on a Thomas Hoover melting 
point apparatus, and are uncorrected. Analytical thin-layer 
chromatography was performed on Merck silica-gel 60F-254 pre-coated (0.2 
mm) plastic or glass-backed sheets. Methods used for visualization were 
ultraviolet light and exposure to iodine vapor. Flash chromatography was 
performed using Woelm 32-63M silica gel according to Still.14
IDENTIFICATION METHODS
Proton nuclear magnetic resonance spectra were recorded on a 
Varian XL-200 (200 MHz), or a Varian QE-300, or a GE-500 spectrometer. 
The chemical shifts are reported in ppm, relative to tetramethysilane as an 
internal standard (d scale). All NMR data has been reported in the 
following manner: d value (multiplicity o f peak, number o f protons, 
chemical coupling constant). Infrared Spectra (IR) were taken from an 
IBM IR/32 FTIR spectrophotometer using CHCls as a solvent. Diagnostic 
signals or bands from IR are reported in cm-1. Low Resolution Electron 
Impact Mass Spectra were obtained from a Finnigan MAT CH-5 
spectrophotometer. The Microanalytical Service Laboratory o f the 
University o f Illinois in the School o f Chemical Sciences performed all 
elemental analyses.
CHEMICALS
All chemicals and solvents were obtained from the following
companies unless otherwise noted: Aldrich, Alfa, Mallinckrodt, Sigma, 
and Fisher. N ,N ^f ,N'-tetramethylethylenediamine was distilled from n-
BuLi immediately before use. Tetrahydrofuran (THF) was distilled from 
sodium/benzophenone prior to use. Hexamethylphosphoramide (HMPA) 
was dried over 4 angstrom molecular sieves. Dimethylsulfide (DMS) was 
fractionally distilled from CaHg immediately before use.
Preparation o f 1-Tetralone Tosvlhvdrazone (12)
a-Tetralone (1.66 g, 11.35 mmol) was introduced into a dry 100 mL- 
flask containing 40 mL of absolute ethanol. An equimolar amount o f p- 
toluenesulfonylhydrazine (2.11 g, 11.35 mmol) was slowly added to the flask, 
followed by the addition of a catalytic amount o f p-toluenesulfonic acid 
monohydiate. The mixture was placed under nitrogen and heated to 
reflux. After 10 min at reflux, a white solid began to precipitate from the 
coral-colored solution. After 30 more minutes, TLC indicated the reaction 
was complete. The precipitate was collected by vacuum and washed with 
small amounts o f cold ethanol, giving 2.619 g (8.33 mmol) o f crystals, 74% 
yield, mp 175-176.80Cd. iH-NMR (CDCla) dl.90 (quintet, 2H, -CH2 at C-3), 
1.96 (t, 2H, -CHa at C-2), 2.46 (s, 3H, TsCHj), 2.70 (t, 2H, -CHa at C-4), 7.20 
(m, 3H, -H at C*5,6 ,7), 7.32 (d, 2H, J-8.32Hz, ArM on tosyl), 7.93 (d, 3H, 
Jb8.18 Hs, Ar£[ on tosyl), 8.00 (s, 1H, on N). Mass spectmm (70 eV): 338 
(M+, 3.43%), 135 (11.56%), 131 (100%), 91.0 (38.46%). Anal, calcd. for 
C17H18N2O2S; C, 64.96; H.5.77; N, 8.91; 8,10.20. Found; C, 64.95; H.5.66; 
N, 8.89; 8,10.21.
20
21
Preparation QfTributvlBtannane (16)
Freshly distilled N,N,N',N'-Tetramethylethylenediamine (TMEDA) 
(60-70 mL) were introduced into a scrupulously dry 200 mL round bottom 
flask, one neck being equipped with a condensor and a second neck with a 
septum. The solvent was cooled to -45°C using a CH3CN/CO2 bath. n-BuLi 
(15.9 mL, 25.44 mmol) o f n-BuLi was then introduced into the flask via 
syringe. Upon addition, the reaction mixture assumed a cloudy yellow 
color. When the system was at -45°C, the tosyl hydrazone l i i  -2.00 g, 6.36 
mmol) was tapped into the mixture through gooch tubing. Upon addition, 
the mixture turned a fiery orange color which deepened with each partial 
addition. Addition was completed in 15 minutes, and the system was then 
stirred at -45°C for the next 1.60 hours, followed by at least an hour of 
stirring at room temperature. With warming, the mixture turned first a 
thick mustard color, which then abruptly changed to an extremely dark 
browmorange color.
The mixture was recoded to 0°C> and tributyltin chloride (6.9 mL 
,25.44 mmol) was ad^d to the mixture by syringe over a period of 10 
minutes. Upon addition, the mixture color changed to a lemon yellow. The 
reaction stirred for 2.6*3 hours, at which time the mixture was quenched 
with 100 mL HgO. Workup consisted of washing first with 30 mL aliquots of
EtOAc. The organic layers were grouped and washed with 60 mL aliquots 
of first Cu80« and then HgO, followed by a final wash with brine. Hie layer 
was dried over MgSO  ^Kugelrohr distilled, and purified by passage 
through a flash column. Yield of final product, as shown by gas 
chromatography, was 60%. *H NMR (CDCls) d 0.90 (t, 9H, Sn-(CHa)3-CHs), 
1.45 (m, 18H, SMCfigh-CHs), 2.28 (sextet, 2H, -CHaat C-3), 2.73 (t, 2H, -Clfe
22
at C-4), 6.25 (t, 1H, -fl at C-2), 7.10 (m, 4H, ArJi). Mass spectrum (70 eV): 
Anal. cakd. for C^HaeSn; C, 63.03; H, 8.65. Found; C, 60.13; H, 8.94.
tmvl chloride (18)
4-Methoxybenzoic acid (3 g, 19.7 mmol) and 1.7 equivalents o f thionyl 
chloride (3.987 g, 33.5 mmol) were placed in a dry 25 mL- round bottom 
flask. Under nitrogen, the thionyl chloride was brought to reflux (70°C). 
Once all o f the acid had dissolved, a lemon yellow colored solution resulted. 
The reaction was allowed to reflux for 45 min and was then vacuum 
distilled under a pressure o f ca. 0.5 mm. The product was collected as a 
clear colorless liquid. The reaction yielded 2.91g( 17.06 mmol), for a yield of 
87%.
4-Methoxybenzoyl chloride (0.885 g, 4.01 mmol) was dissolved in 6 mL 
of HMPA, followed by 1.7% (4J6 mmol, 1.01 eq) of 3,4-dihydro-1- 
triheSylstsnnanonaphthalene, added via syringe, and dam a catalytic 
amowrt (1.5 mg, 0.0005 eq) of beweyfcUorstts-
yo#ow color, was then heated toteteC in an air atawspfeeve, and allowed to 
•tir at this temperature for 18 Imam. The reaction was brought «e room 
temperature and quenched with H^ J. The water layer was washed with 
ethyl acetate several times, and the collected organic layers wees then 
washed with Ht0 and brine and dried over MgB04. General purification for 
this product was done %  flash chromatography on silica gel, using 40/60 
EtOAc-Hexane as the mobile solvent. Through NMR, the fractions 
containing the product were collected. Crystals were afforded by triturating
these fractions with a hexane/ethanol mix. A first crop (27.4 mg) and a 
second crop (22.6 mg) were collected to give an overall yield of 50 mg (4.7%). 
NOTE: Yields were frequently up to 16%. m pU 5-117°C, ^H-NMR (CDC1,) d 
2.50 (m, 2H, -Cft, at C-3), 2.89 (t, 2H, -CH* at C-4), 3.86 (s, 3H, ArOCJi,), 6.41 
(t, 1H, -fl at C-2), 6.91 (d, 2H, J«8.78 Hz, A rfl ortho to methoxy), 7.89 (d, 2H, 
J«8.69 Hz , ArJJ ortho to ketone). Mass spectrum (70 eV): 264 (M+, 100), 236 
(11.36), 135(96.42). Anal, calcd. for C,»H,«0*; C. 81.79; H .6.10. Found; C, 
81.82; H, 6.11.
AH glaasware was dried before Use. Fresh EtaO (10 mL) were placed 
in a 3 necked 26* mL round bottom flask, and cooled to -65°C by use o f a dry 
ice/acetone bath. Vpott fo rm a l equilibrium, 0.74 mL o f PhLi (1.475 mmol, 
3 eq) wot® introduced into the fiask via syringe. CuBr(SMea) (0.152 g, 0.736 
mmol, 15 eq) tyas Weighed out in the nitrogen bag and promptly placed hi 
d-6 mh nfdimethiyiulfide freshly distilled from CaH^. This solutien was 
Hett introduced dm^Wise into the flask, and the reaction mittum then 
for J$ min. At this Um«. H e ketone (0.130 g, 0 402 mmol. 1 eq) was 
placed hi i  o mL o f fresh THF and added via syringe to the fiask. Upon 
addition. the reaction mixture turned a darker yellow color. The reaction 
ran at -66QC for 30-45 minutes, at which time TLC showed the reaction to ha 
complete. The fiask was then warmed to room temperature. Alter a water 
quench, product was isolated by extraction with EtOAc. The organic layer* 
were Washed With H«0 and brine and dried over MgSO«. The product 
obtained alter evaporation was crystallised from hexane/ethanol and 
yielded 38.3 mg (20%) o f small white crystals, mp 100-103°C. lit-NM ft 
(CDC13) d 2.1 (m» 2H, -C &  at C-4), 3.2 (m, 3H, -H at C-2,3), 3.76 (*, 3H,
ArOCHs, trans diastereomer), 3.82 (s, 3H, ArOCHi. cis diastereomer), 4.96 
(d, 1H, J»8.77 Hz, -H at C -l, trans isomer), 5.14 (d, 1H, J=5,55 Hz, -H at C -l, 
cis isomer), 6.78 (d, 2H, J=8.5 Hz, C -l ArH ortho methoxy group), 6.87 (m, 
2H, -C-H at C-7,8), 7.15 (m, 7H, -C|£.on C-2 phenyl, C-5,6), 7.55 (d, 2H, J* 
8.85, C -l ArH ortho to ketone). Mass spectrum (70 eV): 341.6 (M*. 3.41), 
222.8 (10.88), 205.8 (11.50), 177.8 (12.31), 135.8 (100), 91 (100), 77 (92.71). Anal, 
calcd. for CmHw0 2; C, 84.18; H.6.48. Found; C, 82.97; H.6.57.
The triaryl ether (36.6 mg, 0.1068 mmol) was dissolved in 3 mL of fresh
CHaClgin a 10 mL Reacti-Vial. Under nitrogen, 0.1 mL of BF3-8Me2 was
added via syringe. Upon addition, the reaction mixture turned a golden 
yeUew eolor. 77ie reaction was allowed to stir at room temperature for 0.5 
hours and followed by TLC. TLC revealed that deprotection had not yet 
began: only starting material was present. Another 0.5 mL of the BFaSMes 
rtnaplsT and 1.0 mL of CHaCla were added to the reaction, and the reaction 
was once again followed by TLC. After 18 hours, TLC showed the reaction 
to ha complete. The reaction was quenched with H*0, washed with CH8Cl8l 
Hgl, and finally brine. The organic layers were then dried over M gS04. 
Upon evaporation o f solvent, crystals formed. This material was 
eamynlgNMdJNai bexane/ethanol to yield 13 mg (37%) o f diastereomeric 
r j i r t h  (ae detsaied by « » ) .  ^H-NMR (CDC1.) d 2. W (m, 2H, -CH, at C-3), 
« ! .• < %  at C -4 ),3J6(dt, 1H ,-C H atC -i), 5.66 (d, 1H, -C||atC-l), 
w m .  * . * * 4 1  Me. nt C -l), 7.68 (dd, 2H, J«6.67 Hs, A rfi at C -l),
?  J l  tMs *  *® *»C «*A f,* ), 7 J I  (m, 5H, ArHjtt C-2). Mass spectrum (70 
e V ) t « l ( ^ ,3 .4 i ) ,  136 (11.56),121 (100), 91 (28,46).
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